Healthcare Business

biotech

DBV Technologies Files for IPO, Sort Of

DBV Technologies has filed an F-1 form with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO). At least it is an IPO in the United ...
Read Full Story »
health care

Exagen Diagnostics Files for IPO

Exagen Diagnostics Inc. has filed its S-1 form with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO). No terms were given for the offering, but it ...
Read Full Story »
IPO

A First, Chiropractic IPO Filing: The Joint

The Joint Corp. filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO). No terms were given for the offering, but the ...
Read Full Story »
upgrade

Canaccord Genuity Doubles Price Target for Medivation

Medivation Inc. (NASDAQ: MDVN) received an upgrade from Canaccord Genuity on the heels of it continually increasing its 52-week high over the past month. This upgrade comes on analyst John ...
Read Full Story »
152498601

Flexion Therapeutics Stumbles on Clinical Hold

In the after-hours on Wednesday, Flexion Therapeutics Inc. (NASDAQ: FLXN) made a hard fall on the news of a clinical hold. Usually clinical holds result in some serious fall out ...
Read Full Story »
biotech

Analyst Sees Incyte Worth 70% More

Incyte Corp. (NASDAQ: INCY) has serious upside potential, but the inherent risk within it may be too much for some investors to bear. This stock is not for the risk ...
Read Full Story »
Biotechnology word cloud

Why Endo Wants to Acquire Auxilium So Much

Endo International PLC (NASDAQ: ENDP) made an unsolicited buyout offer to Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL). This news comes right after Auxilium announced that it entered into an agreement to ...
Read Full Story »
95992888

Is Avanir Pharma Fully Valued After Monday’s Rally?

Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) posted amazing gains on Monday following the announcement of a successful Phase 1 trial for AVP-923. On the day, Avanir's stock price rose by 85% to ...
Read Full Story »
ReWalker

ReWalk Goes From Marching to Sprinting

Shares of ReWalk Robotics Ltd. (NASDAQ: RWLK) surged again on Monday, following its initial public offering on Friday. The 3 million shares of common stock from the IPO were priced ...
Read Full Story »
health care

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

For a variety of reasons, the cases of chronic hepatitis in the United States have surged dramatically over the past 20 years. Currently, it is estimated that more than 3.2 ...
Read Full Story »
481519631

Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs

Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) announced positive Phase 2 results for its drug candidate AVP-923. The drug candidate is a potential new therapy for agitation and aggression in patients with ...
Read Full Story »
research

NPS Pharma Enters Cautionary Phase of the FDA Approval Process

NPS Pharmaceuticals Inc. (NASDAQ: NPSP) is trading lower on what sounded like good news. The problem is that headlines often do not reveal the underlying story. After its shares were ...
Read Full Story »
145922793

Deep Discount for Health Care REIT Secondary Offering

Health Care REIT Inc. (NYSE: HCN) has joined the waves of companies looking to raise capital after strong share price gains. The senior living and health care properties real estate ...
Read Full Story »
Biotechnology word cloud

Short Sellers Remain Vigilant Against Biotechs

The short interest report is out for the August 29 settlement date, and 24/7 Wall St. is focusing on the biotech sector. Short sellers are often active in biotech stocks, ...
Read Full Story »
DNA

Virobay Files For Initial Public Offering

Virobay, Inc. has filed with the Securities and Exchange Commission for an initial public offering. There were no terms given for the offering but the filing is for up to $50 million ...
Read Full Story »